Phase I dose-finding and pharmacologic study of cisplatin (P), irinotecan (C), and either capecitabine (X) or infusional 5-FU (F) in patients (pts) with advanced solid tumors

被引：0
|
作者：
Enzinger, Peter C. [1 ]
Earle, Craig [1 ]
Zhu, Andrew [1 ]
Blaskowsky, Lawrence [1 ]
Kulke, Matthew [1 ]
Ryan, David [1 ]
Langford, Lauren [1 ]
Michelini, Ann [1 ]
Meyerhardt, Jeffrey [1 ]
机构：
[1] Harvard Univ, Sch Med, Dana Farber Partners Canc Care, Boston, MA USA
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：106 / 106
页数：1
相关论文
共 50 条
  • [1] Phase I dose-finding study of capecitabine (X) with escalating irinotecan (I) and oxaliplatin (O) in patients (pts) with previously treated solid tumors.
    Samanta, E
    Rigatos, SK
    Triantafillis, M
    Kourtis, S
    Koutsourakis, G
    Papanikitas, K
    Konstantinopoulou, A
    Koussoulas, V
    Aravantinos, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 256S - 256S
  • [2] Phase I dose-finding study of trabectedin (T) in combination with cisplatin (C) in patients (pts) with advanced solid tumors.
    Sessa, C.
    Gallerani, E.
    Del Conte, G.
    Christinat, A.
    Perotti, A.
    Lardelli, P.
    Kahatt, C. M.
    Florez, A.
    Fernandez, C.
    Miani, M.
    Gianni, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] A PHASE I, DOSE-FINDING STUDY OF SUNITINIB (SU) IN COMBINATION WITH CISPLATIN (P) AND 5-FLUOROURACIL (5-FU) IN PATIENTS (PTS) WITH ADVANCED GASTRIC CANCER (GC)
    Gomez-Martin, C.
    Gil-Martin, M.
    Montagut, C.
    Nunez, J. A.
    Salazar, R.
    Puig, M.
    Khosravan, R.
    Tursi, J. M.
    Lechuga, M. J.
    Bellmunt, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 255 - 255
  • [4] Phase I trial of cisplatin, infusional 5-FU and irinotecan in advanced gastric cancer.
    Seguru, A
    Fernández-Martos, C
    Aparicio, J
    Campos, JM
    Vicent, J
    Busquier, I
    Molins, C
    Guillem, V
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 156S - 156S
  • [5] Phase I study of capecitabine (C) in combination with cisplatin (DDP) and irinotecan (IRI) in patients (pts) with advanced solid malignancies
    Sayar, H.
    Verschraegen, C. F.
    Smith, H.
    Rabinowitz, I.
    Lee, F. C.
    Shen, Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Dose-finding phase I clinical and pharmacokinetic study of orally administered irinotecan in patients with advanced solid tumors
    Kuppens, IELM
    Dansin, E
    Boot, H
    Feger, C
    Assadourian, S
    Bonneterre, ME
    Beijnen, JH
    Schellens, JHM
    Bonneterre, J
    CLINICAL CANCER RESEARCH, 2006, 12 (12) : 3774 - 3781
  • [7] Combination therapy with infusional 5-FU and 'Tomudex' for patients (pts) with advanced colorectal cancer - A phase I study
    Harstrick, A
    Mayer, S
    Hilger, R
    Muller, C
    Dohmen, D
    Kloppel, R
    Vanhoefer, U
    Scheulen, ME
    Wilke, H
    Seeber, S
    ANNALS OF ONCOLOGY, 1998, 9 : 35 - 36
  • [8] A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours
    E Boven
    C Massard
    J P Armand
    C Tillier
    V Hartog
    N M Brega
    A M Countouriotis
    A Ruiz-Garcia
    J C Soria
    British Journal of Cancer, 2010, 103 : 993 - 1000
  • [9] Tolerability/safety of sunitinib (SU) on schedule 2/1 in combination with capecitabine (C) in patients (pts) with advanced solid tumors (STs): A phase I dose-finding study
    Chiorean, E. G.
    Sweeney, C. J.
    Verschraegen, C. F.
    Lee, F. C.
    Jones, S. F.
    Rabinowitz, I.
    Tye, L.
    Bello, A.
    Chao, R.
    Burris, H. A., III
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours
    Boven, E.
    Massard, C.
    Armand, J. P.
    Tillier, C.
    Hartog, V.
    Brega, N. M.
    Countouriotis, A. M.
    Ruiz-Garcia, A.
    Soria, J. C.
    BRITISH JOURNAL OF CANCER, 2010, 103 (07) : 993 - 1000
12345